|
Volumn 30, Issue 4, 2002, Pages 215-222
|
Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)
a b c a a d |
Author keywords
Hurler; MLD; MSC; Storage disorders; Stromal cell
|
Indexed keywords
ADOLESCENT;
ADULT;
ALLOTRANSPLANTATION;
ARTICLE;
BONE MARROW CELL;
BONE MARROW TRANSPLANTATION;
CHILD;
CLINICAL TRIAL;
CULTURE TECHNIQUE;
CYTOLOGY;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HISTOCOMPATIBILITY;
HUMAN;
HURLER SYNDROME;
MALE;
MESODERM;
METACHROMATIC LEUKODYSTROPHY;
METHODOLOGY;
NERVE CONDUCTION;
PRESCHOOL CHILD;
TRANSPLANTATION;
TREATMENT OUTCOME;
BONE DEFECT;
BONE DENSITY;
BONE MINERAL;
CELL CULTURE;
CELL ISOLATION;
CLINICAL ARTICLE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FLUORESCENCE IN SITU HYBRIDIZATION;
HEALTH STATUS;
HLA MATCHING;
HUMAN CELL;
MENTAL DEVELOPMENT;
MESENCHYME CELL;
NEUROLOGIC DISEASE;
PHYSICAL DEVELOPMENT;
PRIORITY JOURNAL;
SAFETY;
SIBLING;
SURVIVAL;
TOXICITY;
ADOLESCENT;
ADULT;
BONE MARROW CELLS;
BONE MARROW TRANSPLANTATION;
CELL CULTURE TECHNIQUES;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKODYSTROPHY, METACHROMATIC;
MALE;
MESODERM;
MUCOPOLYSACCHARIDOSIS I;
NEURAL CONDUCTION;
TRANSPLANTATION CHIMERA;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 0036676009
PISSN: 02683369
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bmt.1703650 Document Type: Article |
Times cited : (599)
|
References (25)
|